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Background: A relationship between low levels of serum vitamin D and respiratory infections has been established.
No study has examined the frequency and clinical relevance of vitamin D deficiency in patients with primary ciliary
dyskinesia (PCD).
Methods: Vitamin D levels were measured in 22 PCD patients (7 females, 10.5 years, range, 2–34 years). In PCD,
pulmonary function tests (PFTs), sputum microbiology, self-reported physical activity (PA) level, and quality of life
(QoL) by means of the Saint George’s Respiratory Questionnaire (SGRQ), were also assessed.
Results: Seventy-two percent of PCD patients were vitamin-D deficient-to-insufficient and 28% were sufficient. No
differences in PFTs parameters were found between vitamin D deficiency-to-insufficiency and sufficiency groups.
Patients with vitamin D deficiency-to-insufficiency had significantly higher SGRQ total scores, and thus poorer QoL
(p = 0.03). Seventy-nine percent of PCD subjects had limitations in performing vigorous activities, and 53%
performed less than 3 hours of PA per week. Vitamin D deficiency-to-insufficiency and sufficiency groups did not show
any differences in age at PCD diagnosis or at onset of respiratory symptoms, BMI, atopy, current asthma or bronchiectasis.
However, 79% of patients with bronchiectasis had vitamin D deficiency-to-insufficiency. No differences were found in the
rate of positive sputum cultures and in the number of antibiotic courses between the two groups.
Conclusions: Hypovitaminosis D is common in PCD patients, and is associated with poorer QoL. We recommend the
assessment and treatment of hypovitaminosis D to be included in the routine management of PCD.
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Primary ciliary dyskinesia (PCD), a genetic disorder of
cilia function and ultrastructure with situs viscerum
inversus occurring in 50% of patients, is characterized by
impaired mucociliary clearance and recurrent-to-chronic
respiratory infections [1]. Early presenting symptoms in-
clude neonatal respiratory distress and upper airway dis-
ease. Lower airways are commonly involved in PCD, and
recurrent pneumonia, chronic asthma-like symptoms,
and bronchiectasis are the hallmarks of the disease [2].
As a consequence, pulmonary function becomes pro-
gressively impaired and respiratory failure may eventu-
ally occur [3,4].* Correspondence: santamar@unina.it
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unless otherwise stated.Although vitamin D plays a major role in bone health,
recent evidence suggests that low levels may contribute
to several chronic diseases [5,6]. A number of studies in-
dicate that individuals with lower vitamin D are at higher
risk of respiratory infections [7-10]. Vitamin D deficiency
is common also in adults with non-cystic fibrosis (CF)
bronchiectasis, a condition characterized by a vicious cir-
cle of airway inflammation and infection [11].
In PCD, failure of mucus clearance system due to de-
fective ciliary function results in reduced airway defense
against bacteria [1]. To our knowledge, the links be-
tween vitamin D and PCD lung disease have never been
investigated. We hypothesize that, likewise other chronic
respiratory disorders, patients with PCD may have hypo-
vitaminosis D. Therefore, we measured the total circulat-
ing levels of 25-hydroxy cholecalciferol [25(OH)D] in
children, adolescents and adults with stable PCD lunghis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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centrations were associated with pulmonary function pa-
rameters, sputum culture, patients’ quality of life (QoL),
and self-reported physical activity (PA) level.
Methods
Patient population
We conducted a prospective, cross-sectional study of 22
consecutive PCD subjects (median age, 10.5 years; range,
2–34 years; 7 adults; 7 females) attending the Department
of Translational Medical Sciences, Federico II University,
Naples, Italy, the reference center for PCD in Campania,
Southern Italy. Patients lived in Naples metropolitan area
(latitude, 40° 49’ N; elevation, 17 m) and were evaluated
from March through June 2012. Diagnosis of PCD was
made at a median age of 5.9 years (range, 0.1-27) and was
based on the demonstration of abnormal motility and ul-
trastructural defects of cilia. Eighty-two percent of patients
(18/22) had situs viscerum inversus, nobody had hetero-
taxy. Table 1 summarizes the characteristics of the study
population. Thirty-two percent of cases had atopy that
was diagnosed on the basis of the results of skin prick
tests. Current asthma occurred in 36% of patients, as
assessed by standardized questionnaires [12,13]. Sixty-four
percent of cases (14/22) had bronchiectasis at chest high
resolution computed tomography performed in stable
conditions at least in the previous 6 months for assessing
disease severity at some time point during follow-up. In-
clusion criteria were a confirmed diagnosis of PCD, and
PCD lung disease stability was defined as previouslyTable 1 Characteristics of patients with primary ciliary
dyskinesia (n = 22)
Clinical data
Age (yr) 10.5 [2-34]a
Gender (F/M) 7/15
Situs viscerum inversus, n (%) 18 (82)
BMI, kg/m2 18.5 [13-37]a
Age to diagnosis, yrs 6 (0.1-27)a
Age at onset of respiratory symptoms, yrs 0.08 (0–9.5)a
Atopy, n (%)b 7 [32]
Current asthma, n (%) 8 [36]
Bronchiectasis at high resolution
computed tomography, n (%)
14 (64)
Cilia ultrastructural defects, n (%)
Outer or combined outer and inner dynein arms absence 12 (77)
Isolated inner dynein arm absence 2 [9]
Isolated axonemal disorganization 1 [5]
Axonemal disorganization and inner dynein arm absence 2 [9]
aMedian and range values.
bDefined on the basis of results of skin testing to the most common seasonal
and perennial local allergens.reported [14]. Exclusion criteria were: airway infections or
asthma exacerbations during the 4 weeks prior to enroll-
ment; current smoking; long term use of oral steroids at
any dose; antibiotic treatment in the last 4 weeks before
enrollment; prescription of over-the-counter calcium or
vitamin-D supplements prior to, or during the study
period. None of the subjects had any neoplastic, metabolic,
hepatic, and cardiovascular or other concurrent medical
disorders (i.e., renal or malabsorptive diseases). All partici-
pants reported neither being current smokers nor having
been exposed to smoke in the previous 4 weeks.
On the study day, in the morning, patients underwent
serum vitamin D levels measurement, pulmonary function
tests (PFTs), deep throat or sputum culture, and com-
pleted health-related QoL and self-reported PA question-
naires. The procedures were in accordance with the
Helsinki Declaration guidelines on human experimenta-
tion. The study was conducted without any support from
the pharmaceutical industry, after approval by the local in-
stitutional review board. Subjects or their legal guardians
gave informed written consent after extensive information
about the study procedures.
Vitamin D measurement
A single determination of vitamin D levels, measured as
total 25(OH)D, was performed on blood samples obtained
between 08:00 a.m. and 09:00 a.m. after overnight fast,
using the chemiluminescent method (Liasion, DiaSorin,
Saluggia, Italy) [15]. Vitamin D levels were categorized as
being sufficient when >30 ng/ml (>75 nmol/L), insufficient
between 20 and 30 ng/ml (50 and 75 nmol/L), and defi-
cient when <20 ng/ml (<50 nmol/L) [6].
Pulmonary function testing
Cooperating PCD subjects underwent PFTs (Master-
Screen®Body, VIASYS Healthcare GmbH, Wuerzburg,
Germany). Forced vital capacity (FVC), forced expiratory
volume in 1 second (FEV1), forced expiratory flow be-
tween 25% and 75% of FVC (FEF25–75), functional re-
sidual capacity (FRC), and residual volume (RV) were
expressed as % of predicted, while FEV1/FVC ratio was
expressed as % [16].
Quality of life and self-reported physical activity
assessment
In order to assess health-related QoL, 19/22 patients with
PCD (86%) aged ≥6 years completed the St. Georges
Respiratory Questionnaire (SGRQ; 17), a disease-specific
measure developed for asthma and chronic obstructive
pulmonary disease (COPD) that has been validated also in
children and adults with PCD [18,19]. SGRQ score ranges
from 0 to 100 (100 indicating the maximum impairment).
The youngest children were helped by their parents in an-
swering the SGRQ questions. We also administered a
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for assessing their self-reported PA [20].
Microbiological evaluation
Based on cultures results, we defined chronic bacterial
colonization as persistence of specific bacteria for at
least 6 months, with at least 3 positive cultures [4]. For
each subject we also recorded the number of antibiotic
courses performed in the past 12 months. All investiga-
tors were blinded to the other results.
Statistical analysis
Data are presented as median and range. Mann–Whitney
U test and Fisher’s test assessed comparisons among vari-
ables. A p value <0.05 was considered statistically signifi-
cant. Data were analyzed with a statistical software
package (SPSS-PC, version 13.0; SPSS; Chicago, IL).
Results
Median serum 25(OH)D levels in PCD were 25 ng/mL
(4.8-49). Seventy-two percent of patients had vitamin D
deficiency-to-insufficiency, with 4/22 cases (18%) exhibiting
25(OH)D levels <20 ng/ml and 12/22 patients (54%) having
20–30 ng/ml, while 6/22 cases (28%) had >30 ng/ml.
Figure 1 illustrates the serum 25(OH)D levels in PCD
patients with vitamin D deficiency, insufficiency and
sufficiency.
Twelve cooperative PCD subjects underwent PFTs.
Median FVC, FEV1, and FEF25–75 were 97% (58–134),
86% (40–111), and 49% (16–100) predicted, respectively,
while the FEV1/FVC ratio was 73% (58–85). Median
FRC and RV were 87% (46–173) and 74% (18–275) pre-
dicted, respectively. No significant differences in PFTsFigure 1 Serum 25(OH)D levels in PCD patients with vitamin D deficiewere found between vitamin D deficiency-to-insufficiency
and vitamin D sufficiency groups (p >0.05).
Total SGRQ score was 19 (9–65). PCD patients with
vitamin D deficiency-to-insufficiency had significantly
higher total scores at SGRQ (20 versus 17, p = 0.03) than
those with vitamin D sufficiency. In the responses to
the questions on PA, 10% of patients reported being
moderately-to-highly limited, 26% slightly limited, and
63% not limited at all by respiratory symptoms in
everyday-life activities. Fifty-two percent of cases re-
ported moderate-to-severe limitations in performing
vigorous activities, while 26% had only slight difficulties,
and 21% denied any difficulty at all. Fifty-three percent
of patients performed less than 3 hours of physical
training every week, while only 5% spent more than
7 hours. Respiratory symptoms limited everyday-life ac-
tivities at least slightly in 38% and 33% of patients with
vitamin D deficiency-to-insufficiency or sufficiency, re-
spectively (p = 1). Vigorous activity appeared at least
slightly limited in 77% and 83% of the cases with vita-
min D deficiency-to-insufficiency or sufficiency, re-
spectively (p = 1). Fifty-four percent of subjects with
vitamin D deficiency-to-insufficiency and 33% of pa-
tients with sufficiency reported performing > 2 hours
per week of physical training (p = 0.6).
Vitamin D deficiency-to-insufficiency and sufficiency
groups did not show any significant differences in BMI
(19 versus 17 Kg/m2, p = 0.7) and in the ages at PCD
diagnosis (8.3 versus 2.3 years, p = 0.4) or at the onset of
respiratory symptoms (13.5 versus 6.8 years, p = 0.7). No
significant difference was found in vitamin D levels from
atopic and non atopic patients (21.9 versus 27.9 ng/ml,
p = 0.5), from asthmatic and non asthmatic subjectsncy, insufficiency and sufficiency.
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or without bronchiectasis (24.5 versus 30.4 ng/ml, p =
0.6). Within the bronchiectasis group, 11 out of 14 cases
(79%) had vitamin D deficiency-to-insufficiency and 3
patients (21%) had vitamin D sufficiency, while among
the 8 cases with no bronchiectasis 5 (62%) had vitamin
D deficiency-to-insufficiency and 3 (38%) had vitamin D
sufficiency (p = 0.6).
Deep throat or sputum cultures were negative in 13/22
subjects (59%). The most frequently isolated pathogens
were Haemophilus influenzae (27%), Staphylococcus aur-
eus (14%), Streptococcus pneumoniae (9%), Klebsiella spp
(9%), and Pseudomonas aeruginosa (4%). No significant
difference in the rate of positive cultures was found be-
tween the vitamin D deficiency-to-insufficiency and the
sufficiency groups (68% versus 50%, p = 0.6). Only 2 pa-
tients with vitamin D insufficiency met the criteria for
chronic colonization by Haemophilus influenzae. No pa-
tients were chronically colonized by P. aeruginosa.
During the 12 months preceding the study, patients
had undergone a median of 4 antibiotic courses (range,
0–7), but no difference was found between vitamin D
deficient-to-insufficient and sufficient subjects (3.5 ver-
sus 4 courses, p = 0.9).
Discussion
To our knowledge, vitamin D status has never been in-
vestigated in PCD. In this pilot, cross-sectional study,
only 28% of PCD patients living at a latitude of 40°52’ N
had sufficient 25(OH)D serum levels during spring. Our
findings show that more than two thirds of PCD chil-
dren have hypovitaminosis D, which is associated with
worse quality of life. However, we could not find any sig-
nificant relation between PCD-associated vitamin D sta-
tus and pulmonary function, sputum microbiology, past
exacerbations, atopy, or current asthma.
In addition to latitude and season, factors affecting
vitamin D status include skin pigmentation, sun-related
behavior, obesity, vitamin D dietary intake and outdoor/
indoor activities, or also reduced ultraviolet B (UVB) ra-
diations due to atmospheric pollution [5,6,21-23]. Our
study was not designed to investigate the reasons for low
levels of serum vitamin D. However, in our population
BMI excluded obesity, but self reported PA indicated that
patients were quite sedentary. A high proportion of cases
(79%) had limitations in performing vigorous activities,
and approximately 50% spent less than 3 hours per week
doing PA, thus suggesting that PCD likely makes patients
inactive [20,24].
PCD leads to chronic respiratory symptoms and loss
of lung function, with great impact on health and signifi-
cant restriction of life-style [25,26]. The association of
vitamin D levels with quality of life in PCD patients may
be explained by noncalcemic effects of vitamin D [6].Vitamin D has an antimicrobial activity especially against
airway pathogens. In bronchial epithelial cells, vitamin D
increases the expression of cathelicidins which may pre-
vent bacterial infections [27]. Cord blood levels of 25(OH)
D have a strong inverse association with early life airways
infections [8]. Vitamin D supplementation significantly re-
duced the risk of influenza A among Japanese schoolchil-
dren [7] and of winter infections in vitamin D deficient
Mongolian children [9]. Of interest is that the need for an-
tibiotics decreases in older adults treated with oral vitamin
D [10]. Finally, the resolution of inflammatory responses
during tuberculosis treatment is accelerated by the
addition of vitamin D [28]. Also chronic lung disorders
have been associated to vitamin D status. Increased inci-
dence of asthma and vitamin D deficiency appear related,
and the decreased defense against airway pathogens trig-
gering childhood and adulthood wheezing primarily ac-
counts for this [29,30]. Moreover, reduced asthma control,
lung function impairment and airway remodeling signifi-
cantly correlate with hypovitaminosis D [31-33]. Vitamin
D deficiency and chronic obstructive pulmonary disease
(COPD) appear strongly associated, likely because of sub-
jects’ physical impairment and reduced PA, patients’ old
age which is frequently associated with low vitamin levels,
continuous steroid treatment inducing vitamin D catabol-
ism, and malnutrition [34]. Vitamin D deficiency is com-
mon in adult non-CF/non-PCD bronchiectasis and
correlates with disease severity, although the mechanism
is unclear [11]. Likewise non-CF bronchiectasis, the
recurrent-to-chronic infectious nature of PCD pulmonary
disease might be associated to vitamin D status, and this
prompted us to investigate on it. Of interest is that hypovi-
taminosis D is almost universal in CF, due to a combin-
ation of inadequate absorption, impaired metabolism, and
lack of sun exposure [35]. Chest sepsis, albeit milder in
PCD than CF, is a feature of both disorders [36]. However,
vitamin D malabsorption is not seen in PCD, and hence,
the pathogenesis of hypovitaminosis D in PCD can be
somewhat different.
Markedly reduced nasal nitric oxide (nNO) is typical of
PCD [37,38]. Explanations include NO trapping and sub-
sequent breakdown in the airways due to mucus accumu-
lation or paranasal sinuses agenesis [39,40], or also
reduced nNO synthesis due to decreased expression, or
abnormal activity of nitric oxide synthase (NOS) isoen-
zymes [40]. Regulation of NOS potentially contributes to
the antimicrobial effects of vitamin D, but conflicting data
were reported, ranging from a 1,25(OH)2D3-mediated in-
duction of NOS expression in a human macrophage-like
cell line to inhibitory actions of 1,25(OH)2D3 on NOS
[41,42]. These findings indicate an association between
vitamin D and NO production [43], and it is tempting to
suppose that the NO-vitamin D relationship plays a role
also in the PCD airways host defence.
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from a single centre could affect generalizability and,
perhaps, the absence of significant differences among
groups. However, the condition is rare, and this, com-
bined with the criteria of stable disease, likely restricted
patients’ inclusion. We did not compare stable versus
unstable patients for determining the potential of exac-
erbations and/or the effect of antibiotics on vitamin D
status. The cross-sectional nature of the study did not
allow to evaluate vitamin D status longitudinally, par-
ticularly after adequate supplementation. We did not as-
sess the patients’ daily dietary vitamin D intake, and
finally, we did not measure vitamin D-binding protein, a
serum protein with immunomodulatory functions that,
as well as vitamin D, could be relevant in PCD [44]. Not-
withstanding these drawbacks, our study provides the
novel valuable information that a high proportion of
PCD subjects have vitamin D deficiency-to-insufficiency,
with worse QoL than sufficient patients. Determination
of vitamin D levels in the early phases of PCD might
also clarify the mechanism underlying the association
between the two events, including whether the former
precedes the latter. In COPD, osteoporosis also due to
abnormal vitamin D status increases morbidity [45]. Sur-
prisingly, osteoporosis was never investigated in PCD.
Hopefully, following our novel information, a study might
be promoted for preventing or treating potential PCD-
associated osteoporosis.
In conclusion, our findings show that stable PCD chil-
dren and adults commonly have hypovitaminosis D, with
poorer quality of life than those without. This suggests
that assessment of serum vitamin D levels might be in-
cluded in the management of PCD patients. However,
larger studies are warranted to clarify the relationship
between hypovitaminosis D and PCD lung disease.
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